Private Capital Advisors Inc. Sells 604 Shares of Danaher Corporation $DHR

Private Capital Advisors Inc. reduced its position in Danaher Corporation (NYSE:DHR) by 1.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 55,749 shares of the conglomerate’s stock after selling 604 shares during the quarter. Danaher comprises about 1.3% of Private Capital Advisors Inc.’s holdings, making the stock its 20th biggest holding. Private Capital Advisors Inc.’s holdings in Danaher were worth $11,013,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of DHR. Nuveen LLC bought a new position in shares of Danaher in the first quarter valued at approximately $833,941,000. Invesco Ltd. boosted its position in shares of Danaher by 44.5% in the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock valued at $965,259,000 after acquiring an additional 1,450,703 shares during the period. Baird Financial Group Inc. raised its stake in Danaher by 290.6% in the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock valued at $295,550,000 after purchasing an additional 1,072,617 shares in the last quarter. Generation Investment Management LLP raised its stake in Danaher by 33.2% in the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock valued at $651,515,000 after purchasing an additional 791,662 shares in the last quarter. Finally, Parnassus Investments LLC raised its stake in Danaher by 23.3% in the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock valued at $784,745,000 after purchasing an additional 722,636 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Rothschild & Co Redburn reaffirmed a “neutral” rating and issued a $220.00 target price (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Robert W. Baird boosted their price objective on shares of Danaher from $229.00 to $236.00 and gave the company an “outperform” rating in a research report on Wednesday, October 15th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a report on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $245.00.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 11.20% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $221.13 on Wednesday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $269.24. The firm has a market cap of $158.34 billion, a price-to-earnings ratio of 47.05, a price-to-earnings-growth ratio of 3.01 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The business has a 50-day simple moving average of $202.07 and a two-hundred day simple moving average of $197.59.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the firm earned $1.71 EPS. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio is currently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.